Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AstraZeneca PLC | Stockholm | Healthcare | Pharmaceuticals | SEK 2.26T | 31.8x | 1.83 | SEK 1,465.50 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.5% Upside | Upgrade to Pro+ | |
Swedish Orphan Biovitrum | Stockholm | Healthcare | Pharmaceuticals | SEK 99.39B | 25.4x | 0.49 | SEK 289.80 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 32.1% Upside | Upgrade to Pro+ | |
Camurus AB | Stockholm | Healthcare | Pharmaceuticals | SEK 35.36B | 81.6x | -21.17 | SEK 602 | -4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.2% Upside | Upgrade to Pro+ | |
Vimian Group AB | Stockholm | Healthcare | Pharmaceuticals | SEK 21.19B | 100.6x | 1.24 | SEK 40.10 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24.9% Upside | Upgrade to Pro+ | |
Bonesupport | Stockholm | Healthcare | Pharmaceuticals | SEK 20.09B | 150.3x | -3.53 | SEK 304.20 | -5.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 39.7% Upside | Upgrade to Pro+ | |
BioGaia B | Stockholm | Healthcare | Pharmaceuticals | SEK 10.91B | 30.7x | -8.47 | SEK 107.70 | -3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 46.5% Upside | Upgrade to Pro+ | |
Swedencare | Stockholm | Healthcare | Pharmaceuticals | SEK 6.09B | 61.1x | 0.9 | SEK 38.30 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 47.6% Upside | Upgrade to Pro+ | |
Flerie AB | Stockholm | Healthcare | Pharmaceuticals | SEK 3.52B | -13.7x | -0.22 | SEK 45.03 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27.3% Upside | Upgrade to Pro+ | |
Enzymatica publ AB | Stockholm | Healthcare | Pharmaceuticals | SEK 1.13B | -17.1x | -2.49 | SEK 4.66 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -39.8% Downside | Upgrade to Pro+ | |
Magle Chemoswed | Stockholm | Healthcare | Pharmaceuticals | SEK 660.62M | 21.3x | 0.36 | SEK 32.20 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 48.1% Upside | Upgrade to Pro+ | |
Cinclus Pharma Holding AB | Stockholm | Healthcare | Pharmaceuticals | SEK 549.33M | -3.4x | -0.08 | SEK 11.84 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Dicot | Stockholm | Healthcare | Pharmaceuticals | SEK 547.86M | -5.3x | -0.23 | SEK 0.31 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Orexo AB | Stockholm | Healthcare | Pharmaceuticals | SEK 527.93M | -2.6x | 0.04 | SEK 15.30 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 33.1% Upside | Upgrade to Pro+ | |
Infant Bacterial Therapeutics | Stockholm | Healthcare | Pharmaceuticals | SEK 471.50M | -3.4x | 1.53 | SEK 34.90 | 2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Moberg Pharma | Stockholm | Healthcare | Pharmaceuticals | SEK 370.28M | -1.2x | 0 | SEK 7.93 | -5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 32.9% Upside | Upgrade to Pro+ | |
IRLAB Therapeutics | Stockholm | Healthcare | Pharmaceuticals | SEK 347.52M | -4.3x | -0.08 | SEK 6.70 | -4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Lipum | Stockholm | Healthcare | Pharmaceuticals | SEK 324.55M | -4.6x | -0.22 | SEK 15.30 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Isofol Medical | Stockholm | Healthcare | Pharmaceuticals | SEK 321.74M | -7.8x | 0.38 | SEK 1.99 | -3.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Corline Biomedical AB | Stockholm | Healthcare | Pharmaceuticals | SEK 249.81M | -9.3x | 0.01 | SEK 10.20 | 6.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Lipidor | Stockholm | Healthcare | Pharmaceuticals | SEK 235.07M | -7.8x | -0.18 | SEK 0.29 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cessatech AS | Spotlight | Healthcare | Pharmaceuticals | SEK 230.50M | -11.2x | -0.2 | SEK 12.77 | -3.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Enorama Pharma | Stockholm | Healthcare | Pharmaceuticals | SEK 143.32M | -2.9x | -0.08 | SEK 2.37 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vivesto AB | Stockholm | Healthcare | Pharmaceuticals | SEK 126.98M | -3.4x | -0.05 | SEK 0.24 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Elicera Therapeutics AB | Stockholm | Healthcare | Pharmaceuticals | SEK 85.63M | -5.4x | -0.14 | SEK 2.37 | -2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pila Pharma AB | Stockholm | Healthcare | Pharmaceuticals | SEK 84.36M | -7.7x | -1.42 | SEK 3.09 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oncozenge AB | Stockholm | Healthcare | Pharmaceuticals | SEK 71.10M | -8.5x | -0.17 | SEK 5.96 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ExpreS2ion Biotech | Stockholm | Healthcare | Pharmaceuticals | SEK 57.95M | -1x | -0.02 | SEK 22.40 | 4.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Lipigon Pharmaceuticals AB | Stockholm | Healthcare | Pharmaceuticals | SEK 44.35M | -0.9x | -0.2 | SEK 0.30 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Odi Pharma | Spotlight | Healthcare | Pharmaceuticals | SEK 35.01M | -9.3x | 8.61 | SEK 2.70 | 22.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Double Bond Pharma | Spotlight | Healthcare | Pharmaceuticals | SEK 30.31M | -2.2x | -0.08 | SEK 0.28 | -11.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
XP Chemistries AB | Stockholm | Healthcare | Pharmaceuticals | SEK 22.67M | -0.5x | -0.27 | SEK 0.11 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
QuiaPEG Pharmaceutical | Stockholm | Healthcare | Pharmaceuticals | SEK 7.41M | -0.2x | -0 | SEK 0.004 | 10% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |